ARTICLE | Clinical News
(S)-oxybutynin: Started Phase III trial
June 25, 2001 7:00 AM UTC
Sepracor Inc. (SEPR), Marlborough, Mass. Product: (S)-oxybutynin Business: Urological Therapeutic category: Neurotransmission Target: Smooth muscle Description: Single isomer version of oxybutynin an...